|
| 產(chǎn)地 | 進(jìn)口、國(guó)產(chǎn) |
| 品牌 | 上海莼試 |
| 保存條件 | Store at -20 °C |
| 貨號(hào) | CS10760 |
| 應(yīng)用范圍 | WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 |
| CAS編號(hào) | |
| 抗體名 | Anti-phospho-PAK2(Ser141) |
| 克隆性 | |
| 靶點(diǎn) | 詳見說(shuō)明書 |
| 適應(yīng)物種 | 詳見說(shuō)明書 |
| 形態(tài) | 詳見說(shuō)明書 |
| 宿主 | 詳見說(shuō)明書 |
| 亞型 | IgG |
| 標(biāo)識(shí)物 | 詳見說(shuō)明書 |
| 濃度 | 1mg/1ml% |
| 免疫原 | KLH conjugated Synthesised phosphopeptide derived from human PAK2 around the phosphorylation site of (Ser141) |
磷酸化p21激活激酶2抗體說(shuō)明書 英文名稱 Anti-phospho-PAK2(Ser141)
中文名稱 磷酸化p21激活激酶2抗體說(shuō)明書
別 名 C-t-PAK2; CB422; EC 2.7.11.1; Gamma PAK; Gamma-PAK; hPAK65; Kinase; p21 (CDKN1A)-activated kinase 2a; p21 activated kinase 2; p21 protein (Cdc42/Rac)-activated kinase 2; p21 protein Cdc42 Rac activated kinase 2; p21-activated kinase 2; p21-activated kinase, 65-KD; p21-activated protein kinase I; p21CDKN1A activated kinase 2; p27; p34; p58; p65PAK; PAK 2; PAK-2; PAK-2p34; Pak2; PAK2_HUMAN; PAK65; PAKgamma; S6 H4 kinase; S6/H4 kinase; Serine threonine protein kinase PAK 2.
產(chǎn)品屬性：
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Dog, Cow, Horse, Rabbit
產(chǎn)品類型 一抗 磷酸化抗體
研究領(lǐng)域 細(xì)胞生物 微生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 激酶和磷酸酶
蛋白分子量 predicted molecular weight: 23/35/58kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated Synthesised phosphopeptide derived from human PAK2 around the phosphorylation site of (Ser141)
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide
磷酸化p21激活激酶2抗體說(shuō)明書 產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
保存條件 Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.
Important Note This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.
產(chǎn)品介紹 The p21 activated kinases (PAK) are critical effectors that link Rho GTPases to cytoskeleton reorganization and nuclear signaling. The PAK proteins are a family of serine/threonine kinases that serve as targets for the small GTP binding proteins, CDC42 and RAC1, and have been implicated in a wide range of biological activities. The protein encoded by this gene is activated by proteolytic cleavage during caspase-mediated apoptosis, and may play a role in regulating the apoptotic events in the dying cell.
P21-activated kinase (PAK) is actually a family of serine/threonine protein kinases, members of which are activated by small molecular weight GTPases. The three most common isoforms are PAK 1, PAK 2, and PAK 3 (also known as alpha PAK, gamma PAK, and beta PAK, respectively). These kinases contain numerous regulatory elements that trigger diverse signaling processes such as those initiated by activated GTPases, interaction with Src homology 3 (SH3) domains, and caspase mediated proteolytic cleavage. Autophosphorylation of serine 141 (serine 144 for PAK 1 and serine 139 PAK 3), catalyzed by Cdc42, is required for activation of PAK.
Function : Serine/threonine protein kinase that plays a role in a variety of different signaling pathways including cytoskeleton regulation, cell motility, cell cycle progression, apoptosis or proliferation. Acts as downstream effector of the small GTPases CDC42 and RAC1. Activation by the binding of active CDC42 and RAC1 results in a conformational change and a subsequent autophosphorylation on several serine and/or threonine residues. Full-length PAK2 stimulates cell survival and cell growth. Phosphorylates MAPK4 and MAPK6 and activates the downstream target MAPKAPK5, a regulator of F-actin polymerization and cell migration. Phosphorylates JUN and plays an important role in EGF-induced cell proliferation. Phosphorylates many other substrates including histone H4 to promote assembly of H3.3 and H4 into nucleosomes, BAD, ribosomal protein S6, or MBP. Additionally, associates with ARHGEF7 and GIT1 to perform kinase-independent functions such as spindle orientation control during mitosis. On the other hand, apoptotic stimuli such as DNA damage lead to caspase-mediated cleavage of PAK2, generating PAK-2p34, an active p34 fragment that translocates to the nucleus and promotes cellular apoptosis involving the JNK signaling pathway. Caspase-activated PAK2 phosphorylates MKNK1 and reduces cellular translation.
Subunit : Interacts tightly with GTP-bound but not GDP-bound CDC42/p21 and RAC1. Interacts with SH3MD4. Interacts with and activated by -1 Nef. Interacts with SCRIB. Interacts with ARHGEF7 and GIT1. PAK-2p34 interacts with ARHGAP10.
PAK-2p34: Nucleus. Cytoplasm, perinuclear region. Membrane; Lipid-anchor. Note=Interaction with ARHGAP10 probably changes PAK-2p34 location to cytoplasmic perinuclear region. Myristoylation changes PAK-2p34 location to the membrane.
Tissue Specificity : Ubiquitously expressed. Higher levels seen in skeletal muscle, ovary, thymus and spleen.
Post-translational modifications : Full length PAK2 is autophosphorylated when activated by CDC42/p21. Following cleavage, both peptides, PAK-2p27 and PAK-2p34, become highly autophosphorylated, with PAK-2p27 being phosphorylated on serine and PAK-2p34 on threonine residues, respectively. Autophosphorylation of PAK-2p27 can occur in the absence of any effectors and is dependent on phosphorylation of Thr-402, because PAK-2p27 is acting as an exogenous substrate.
During apoptosis proteolytically cleaved by caspase-3 or caspase-3-like proteases to yield active PAK-2p34.
Ubiquitinated, leading to its proteasomal degradation.
PAK-2p34 is myristoylated.
Similarity : Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. STE20 subfamily.
Contains 1 CRIB domain.
Contains 1 protein kinase domain.
Database links : UniProtKB/Swiss-Prot: Q13177.3
PAK1-3蛋白具有廣泛的生物學(xué)功能,也是一個(gè)保守的絲氨酸/蘇氨酸蛋白激酶,參與許多重要的細(xì)胞活動(dòng)。包括細(xì)胞骨架的動(dòng)力學(xué)調(diào)節(jié),細(xì)胞移動(dòng),生存和凋亡,細(xì)胞周期,基因轉(zhuǎn)錄調(diào)節(jié),細(xì)胞生長(zhǎng)信號(hào)轉(zhuǎn)導(dǎo)和轉(zhuǎn)化等。
實(shí)驗(yàn)流程：
全、新、優(yōu)、品、好四大特點(diǎn)：
磷酸化p21激活激酶2抗體說(shuō)明書 全：公司提供上萬(wàn)種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標(biāo)準(zhǔn)品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細(xì)胞等，基本上各種科研所需產(chǎn)品在我司都能找到。
新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。
優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。
好：我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì)，產(chǎn)品一旦售出，實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒有任何的后顧之憂。
正在熱銷的相關(guān)產(chǎn)品：
Anti-CYLD/cylindromatosis 1/FITC 熒光素標(biāo)記兔抗人、大、小鼠微管結(jié)合蛋白CYLD抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Anti-Melamine/Gold 膠體金離子標(biāo)記三聚氰胺單克隆抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh CDKN2B/p15 INK4b 細(xì)胞周期蛋白依賴性激酶抑制劑2B抗體 規(guī)格 0.2ml
phosphor-SMAD(p-Ser425)、phosphor-Mothers against decapentaplegic 磷酸化SMAD(p-Ser425)抗原 0.5mg
IGF1R 英文名稱： 樣生長(zhǎng)因子1受體抗體 0.1ml
Rhesus antibody Rh Thioredoxin 2 線粒體硫氧還蛋白2抗體 規(guī)格 0.1ml
Anti-Melamine/Gold 膠體金離子標(biāo)記三聚氰胺單克隆抗體IgGMulti-class antibodies規(guī)格： 0.2ml
C4d(Human Complement fragment 4d) ELISA Kit 人補(bǔ)體片斷4dMulti-class antibodies規(guī)格： 48T
Anti-Phospho-Raptor (Ser792) 磷酸化mTOR相關(guān)調(diào)控蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
Rhesus antibody Rh Hairless 無(wú)毛發(fā)蛋白抗體 規(guī)格 0.2ml
HSP-20 ELISA Kit 大鼠熱休克蛋白20 96T
PLASTIN3 英文名稱： 絲束蛋白T Plastin抗體 0.2ml
BubR1 英文名稱： 有絲分裂檢驗(yàn)點(diǎn)蛋白BubR1抗體 0.2ml
Anti-Phospho-Raptor (Ser792) 磷酸化mTOR相關(guān)調(diào)控蛋白抗體Multi-class antibodies規(guī)格： 0.1ml
BF ELISA Kit 大鼠B因子Multi-class antibodies規(guī)格： 48T
Anti-AMPK alpha-1 /FITC 熒光素標(biāo)記腺苷單磷酸活化蛋白激酶α1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
Rhesus antibody Rh Fast skeletal Myosin/MRLC2 骨骼肌肌球蛋白輕鏈2抗體 規(guī)格 0.1ml
VEGFR-3/Flt-4(Human Vascuoar endothelial cell growth factor receptor 2) ELISA kit 人內(nèi)皮細(xì)胞生長(zhǎng)因子受體3 96T
phospho-MyoD1(Ser200) 英文名稱： 磷酸化肌原調(diào)節(jié)蛋白抗體 0.1ml
Girdin 英文名稱： 肌動(dòng)蛋白結(jié)合蛋白Girdin抗體 0.1ml
Anti-AMPK alpha-1 /FITC 熒光素標(biāo)記腺苷單磷酸活化蛋白激酶α1抗體IgGMulti-class antibodies規(guī)格： 0.2ml
CL-000422RV1(人細(xì)胞)5×106cells/瓶×2
FKBP14 Others Human 人 FKBP14 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
尿道上皮細(xì)胞生長(zhǎng)添加物UCGS
HEC-1-A細(xì)胞，人子宮內(nèi)膜腺癌細(xì)胞 鼠雜交細(xì)胞,K6H6/B5細(xì)胞 新生兒細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
FC33(人胚胎腎細(xì)胞(Asp-2基因修飾)) 5×106cells/瓶×2
HWP subcutaneous Pellet 人類皮下白前脂肪細(xì)胞團(tuán)塊 > 1 mio.cells 人少突膠質(zhì)前體細(xì)胞(懸浮生長(zhǎng))總RNAHOPC-os NA
CL-00025637(人細(xì)胞)5×106cells/瓶×2
NGF Others Mouse 小鼠 β-NGF / Beta-NGF CHO細(xì)胞裂解液 (陽(yáng)性對(duì)照)
動(dòng)物上皮細(xì)胞生長(zhǎng)添加物-aEpiCGS-2-a
荷蘭黑白花奶牛牛肺細(xì)胞;DCL1 ，SPA-A1細(xì)胞 SCaBER(膀胱鱗癌細(xì)胞)
EB病毒轉(zhuǎn)化的人B淋巴細(xì)胞;KM0501
FZD5 Others Human 人 Frizzled-5 / FZD5 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
磷酸化p21激活激酶2抗體說(shuō)明書 LYZL2 Others Human 人 Lysozyme 2 / LYZL2 桿狀病毒-昆蟲細(xì)胞裂解液 (陽(yáng)性對(duì)照)
中國(guó)倉(cāng)鼠卵巢細(xì)胞(亞系克隆); EPO-CHO-T
淋巴內(nèi)皮細(xì)胞Many types of cells包裝：5 × 105次方(1ml)
人臍動(dòng)脈平滑肌細(xì)胞 人肺，NCI-H2170[H2170]細(xì)胞 L6565(小鼠L6565克隆細(xì)胞系)
TNFa轉(zhuǎn)染耐VP16絨癌細(xì)胞;JEG-3-VP16-TNFa
MMP8 Others Human 人 MMP8 / CLG1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)
技術(shù)外包服務(wù):
★磷酸化p21激活激酶2抗體說(shuō)明書 分子生物學(xué)：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué)：基因合成、引物合成、基因測(cè)序、載體構(gòu)建等
★蛋白工程：原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等
★病毒包裝：腺病毒、慢病毒等
★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等
★細(xì)胞工程：細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。
|
|
|
|
|
